Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dacetuzumab (SGN-40), a humanized IgG1 anti-CD40 monoclonal antibody, exhibits anti-lymphoma activity by inducing tumor cell death through immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). It is utilized in research on multiple myeloma [1].
説明 | Dacetuzumab (SGN-40), a humanized IgG1 anti-CD40 monoclonal antibody, exhibits anti-lymphoma activity by inducing tumor cell death through immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). It is utilized in research on multiple myeloma [1]. |
分子量 | N/A |
CAS No. | 880486-59-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dacetuzumab 880486-59-9 Inhibitor inhibitor inhibit